Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
31,527,213
-
Shares change
-
+6,051,482
-
Total reported value, excl. options
-
$310,226,812
-
Value change
-
+$57,103,339
-
Put/Call ratio
-
75%
-
Number of buys
-
63
-
Number of sells
-
-57
-
Price
-
$9.84
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2017
162 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,527,213 shares
of 80,437,135 outstanding shares and own 39.19% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,260,258 shares), VANGUARD GROUP INC (2,020,039 shares), D. E. Shaw & Co., Inc. (1,977,076 shares), STATE STREET CORP (1,896,674 shares), Boxer Capital, LLC (1,500,000 shares), GREAT POINT PARTNERS LLC (1,468,521 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,331,440 shares), RTW INVESTMENTS, LP (1,305,643 shares), J. Goldman & Co LP (1,261,722 shares), and Camber Capital Management LLC (1,250,000 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.